nejm retatrutide phase 2 2023 percent weight loss 48 weeks Retatrutide (not yet approved in US but people using anyway) promises even potentially greater weight loss amongst the GLP1 drugs. https://www.nejm .org/doi/full/10.1056/NEJMoa2301972 Retatrutide 16mg – NewBioRx

GLP-1 Therapy Part 1: Setting Realistic Weight Loss Expectations I recently had the pleasure of speaking at the Colorado Academy of Nutrition and Dietetics Annual Conference on the topic of nutrition strategies for effective GLP-1 use in obesity treatment

Care model and oversight: Hims is designed around asynchronous intake and messaging

Get In Touch With Us GLP-1 Lawsuit MDL Update (JuneNovember 2025) From June through November 2025, the GLP-1 receptor agonist multidistrict litigation (MDL 3094) expanded rapidly, with the number of pending lawsuits increasing from approximately 1,882 cases in early June to more than 2,900 cases by early November , according to reports from the Judicial Panel on Multidistrict Litigation (JPML)

You might like to learn how Vyvanse compares with other similar medications

Types of electrolyte products Electrolyte powder packets

If youre taking a GLP-1 and trying to figure out the best way to exercise, here are a few extra tips to get you moving and keep you motivated